• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[儿童侵袭性感染的危险因素及耐药模式]

[Risk factors and resistance patterns of invasive infection in Children].

作者信息

Ge Y L, Shan Q W, Qiu Y, Zhou S P, Cheng Y B, Wang F, Yang J W, Wan C M, Zhu Y, Xu Y, Chen M X, Lin D J, Zhu C H, Zeng Mei

机构信息

Department of Infectious Diseases, Children's Hospital of Fudan University, Shanghai 201102, China.

Department of Pediatrics, First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.

出版信息

Zhonghua Er Ke Za Zhi. 2022 Aug 2;60(8):762-768. doi: 10.3760/cma.j.cn112140-20220502-00404.

DOI:10.3760/cma.j.cn112140-20220502-00404
PMID:35922185
Abstract

To understand the risk factors and antibiotics-resistant patterns of invasive infection in Children. This retrospective study was conducted in 6 tertiary hospitals from January 2016 to December 2018. The basic information, clinical data and the results of antimicrobial susceptibility testing were collected from the 98 pediatric inpatients with isolated from blood or cerebrospinal fluid and analyzed. According to the susceptibility of the infected strains to carbapenems, they were divided into carbapenem-sensitive (CSAB) group and carbapenem-resistant (CRAB) group. According to the possible sources of infection, they were divided into nosocomial infection group and community infection group. Chi-square test or Fisher exact test were used to analyze categorical variables and rank sum test were used to analyze continuous variables. The risk factors of invasive CRAB infection in children were analyzed by Logistic regression. There were 56 males and 42 females in 98 cases. The onset age of patients was 8 (2, 24) months. There were 62 cases (63%) from rural area. A total of 87 cases (89%) were confirmed with bloodstream infection, and 12 cases (12%) confirmed with meningitis (1 case was accompanied with bloodstream infection). In these patients, 66 cases (67%) received invasive medical procedures or surgery, 54 cases (55%) received carbapenems-containing therapy. Twenty-four cases were infected with CRAB, and 74 cases with CSAB. The onset age of cases in CRAB group was lower than that in CSAB group (4 (1, 9) 10 (4, 24) months, -2.16, =0.031). The proportions of hospitalization in intensive care unit, carbapenem antibiotics using, pneumonia and adverse prognosis in CRAB group were higher than those in CSAB group (6 cases (25%) 4 cases (5%), 18 cases (75%) 36 cases (49%), 17 cases (71%) 17 cases (23%), 6 cases (25%) 4 cases (5%), χ=5.61, 5.09, 18.32, 5.61, all <0.05). Seventy-seven cases were nosocomial infection and 21 cases were hospital-acquired infection. The proportion of children hospitalized in high-risk wards for nosocomial infections, length of hospitalization, number of antimicrobial therapy received and duration of antimicrobial therapy were higher in the hospital associated infection group than those in the community acquired infection group (all <0.05). Logistic regression analysis showed that children from rural area (=8.42, 95% 1.45-48.88), prior mechanical ventilation (=12.62, 95% 1.31-121.76), and prior antibiotic therapy (=4.90, 95% 1.35-17.72) were independent risk factors for CRAB infection. The resistance percentage of CSAB isolates to many classes of antibiotics was <6% except to gentamicin, which was as high as 20% (13/65). All CRAB isolates of resistant to ampicillin-sulbactam (20/20), cefepime (23/23), piperacillin (17/17), meropenem (23/23) and imipenem (24/24) were 100%. The resistance percentage to other antibiotics were up to 42%-96%. Most of invasive infection in children in China are hospital-acquired. The outcome of invasive CRAB infection was poorer than that of CSAB infection. The drug resistance rate of CRAB strains isolated is high. Living in rural area, prior invasive mechanical ventilation and prior antibiotic therapy were independent risk factors for invasive CRAB infection. The prevention and control of nosocomial infection and appropriate use of antibiotics to reduce infection.

摘要

了解儿童侵袭性感染的危险因素及抗生素耐药模式。本回顾性研究于2016年1月至2018年12月在6家三级医院开展。收集了98例血或脑脊液分离出病原菌的儿科住院患者的基本信息、临床资料及药敏试验结果并进行分析。根据感染菌株对碳青霉烯类药物的敏感性,将其分为碳青霉烯敏感(CSAB)组和碳青霉烯耐药(CRAB)组。根据可能的感染源,分为医院感染组和社区感染组。采用卡方检验或Fisher确切检验分析分类变量,采用秩和检验分析连续变量。采用Logistic回归分析儿童侵袭性CRAB感染的危险因素。98例患者中,男性56例,女性42例。患者发病年龄为8(2,24)个月。62例(63%)来自农村地区。共87例(89%)确诊为血流感染,12例(12%)确诊为脑膜炎(1例合并血流感染)。这些患者中,66例(67%)接受了侵入性医疗操作或手术,54例(55%)接受了含碳青霉烯类药物的治疗。24例感染CRAB,74例感染CSAB。CRAB组患者的发病年龄低于CSAB组(4(1,9)个月对10(4,24)个月,Z=-2.16,P=0.031)。CRAB组在重症监护病房住院、使用碳青霉烯类抗生素、肺炎及不良预后的比例均高于CSAB组(6例(25%)对4例(5%),18例(75%)对36例(49%),17例(71%)对17例(23%),6例(25%)对4例(5%),χ²=5.61、5.09、18.32、5.61,均P<0.05)。77例为医院感染,21例为社区获得性感染。医院相关感染组儿童在医院感染高危病房住院比例、住院时间、接受抗菌治疗次数及抗菌治疗持续时间均高于社区获得性感染组(均P<0.05)。Logistic回归分析显示,来自农村地区的儿童(OR=8.42,95%CI 为1.4548.88)、既往机械通气(OR=12.62,95%CI 为1.31121.76)及既往抗生素治疗(OR=4.90,95%CI 为1.3517.72)是CRAB感染的独立危险因素。CSAB分离株对多种抗生素的耐药率均<6%,但对庆大霉素耐药率高达20%(13/65)。所有CRAB分离株对氨苄西林舒巴坦(20/20)、头孢吡肟(23/23)、哌拉西林(17/17)、美罗培南(23/23)和亚胺培南(24/24)的耐药率均为100%。对其他抗生素的耐药率高达42%96%。我国儿童侵袭性感染大多为医院获得性。侵袭性CRAB感染的预后较CSAB感染差。分离出的CRAB菌株耐药率高。居住在农村地区、既往侵入性机械通气及既往抗生素治疗是侵袭性CRAB感染的独立危险因素。应防控医院感染并合理使用抗生素以减少感染。

相似文献

1
[Risk factors and resistance patterns of invasive infection in Children].[儿童侵袭性感染的危险因素及耐药模式]
Zhonghua Er Ke Za Zhi. 2022 Aug 2;60(8):762-768. doi: 10.3760/cma.j.cn112140-20220502-00404.
2
Insights into the epidemiology, risk factors, and clinical outcomes of carbapenem-resistant infections in critically ill children.重症儿童耐碳青霉烯类感染的流行病学、危险因素和临床结局的研究进展。
Front Public Health. 2023 Nov 30;11:1282413. doi: 10.3389/fpubh.2023.1282413. eCollection 2023.
3
[Analysis of clinical characteristics and antimicrobial resistance of carbapenem-resistant Acinetobacter baumannii infections in children].儿童耐碳青霉烯类鲍曼不动杆菌感染的临床特征及耐药性分析
Zhonghua Er Ke Za Zhi. 2011 Jul;49(7):545-9.
4
[Drug resistance of in pediatric intensive care unit].[儿科重症监护病房中的耐药性]
Zhonghua Er Ke Za Zhi. 2021 Aug 2;59(8):651-657. doi: 10.3760/cma.j.cn112140-20210117-00053.
5
Risk factors and mortality of patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia.医院获得性耐碳青霉烯鲍曼不动杆菌肺炎患者的危险因素和死亡率。
Am J Infect Control. 2013 Jul;41(7):e59-63. doi: 10.1016/j.ajic.2013.01.006. Epub 2013 Mar 21.
6
Prospective multi-center evaluation on risk factors, clinical characteristics and outcomes due to carbapenem resistance in complex bacteraemia: experience from the Chinese Antimicrobial Resistance Surveillance of Nosocomial Infections (CARES) Network.复杂血流感染碳青霉烯耐药的危险因素、临床特征和结局的前瞻性多中心评估:来自中国医院感染抗菌药物耐药监测网(CARES)的经验。
J Med Microbiol. 2020 Jul;69(7):949-959. doi: 10.1099/jmm.0.001222.
7
Analysis of risk factors and different treatments for infections caused by carbapenem-resistant Acinetobacter baumannii in Shaanxi, China.中国陕西耐碳青霉烯类鲍曼不动杆菌感染的危险因素及不同治疗方法分析。
BMC Infect Dis. 2024 Oct 9;24(1):1130. doi: 10.1186/s12879-024-10036-5.
8
Impact of antibiotic exposure on occurrence of nosocomial carbapenem-resistant Acinetobacter baumannii infection: a case control study.抗生素暴露对医院获得性耐碳青霉烯鲍曼不动杆菌感染发生的影响:病例对照研究。
J Infect Chemother. 2015 Feb;21(2):90-5. doi: 10.1016/j.jiac.2014.10.002. Epub 2014 Nov 25.
9
Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes.希腊重症监护病房耐碳青霉烯类 versus 碳青霉烯类敏感鲍曼不动杆菌菌血症:危险因素、临床特征和结局。
Infection. 2010 Jun;38(3):173-80. doi: 10.1007/s15010-010-0008-1. Epub 2010 Mar 12.
10
[Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].[耐碳青霉烯类鲍曼不动杆菌的耐药机制及体外联合用药的应用]
Zhonghua Shao Shang Za Zhi. 2014 Apr;30(2):166-70.

引用本文的文献

1
[Characteristics of drug resistance and biofilm formation in carbapenem-resistant in hospitalized children].[住院儿童碳青霉烯类耐药菌的耐药特性及生物膜形成情况]
Zhongguo Dang Dai Er Ke Za Zhi. 2024 Apr 15;26(4):358-364. doi: 10.7499/j.issn.1008-8830.2309058.